Study to Determine Safety, Tolerability and Pharmacokinetics, of SCO-120 in Healthy Male and Post-menopausal Female Subjects

NCT04242953 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

140

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteer Study

Interventions

DRUG: SCO-120
DRUG: matching placebo

Sponsor

Sun Pharma Advanced Research Company Limited